Pulmonary Hypertension
On this page
Pulmonary hypertension (high blood pressure in the lungs) is a rare and serious blood vessel disorder of the lungs, affecting one or two people in a million.
The UCSF Pulmonary Hypertension Program offers evaluation, diagnosis and treatment of primary pulmonary hypertension (PPH) and secondary pulmonary hypertension, which is often misdiagnosed. The secondary type is a side effect of another condition, such as emphysema or lupus, while PPH is not.
We are one of only three centers on the West Coast designated a comprehensive center of care by the Pulmonary Hypertension Association. This recognition is given to programs that demonstrate superior ability to care for patients with this complex condition and are making important contributions to research.
Pulmonary hypertension (high blood pressure in the lungs) is a rare and serious blood vessel disorder of the lungs, affecting one or two people in a million.
The UCSF Pulmonary Hypertension Program offers evaluation, diagnosis and treatment of primary pulmonary hypertension (PPH) and secondary pulmonary hypertension, which is often misdiagnosed. The secondary type is a side effect of another condition, such as emphysema or lupus, while PPH is not.
We are one of only three centers on the West Coast designated a comprehensive center of care by the Pulmonary Hypertension Association. This recognition is given to programs that demonstrate superior ability to care for patients with this complex condition and are making important contributions to research.
Related services
Nationally recognized excellence
Best in the West and No. 3 in the nation for pulmonology & lung surgery
One of the nation's best for heart & vascular care
Accredited center of comprehensive care (Pulmonary Hypertension Association)
